跳至主要内容
临床试验/NCT05525585
NCT05525585进行中(未招募)不适用

Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants: a Randomized Clinical Trial

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2022年11月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
80
试验地点
1
主要终点
Fat-free mass(FFM)-for-age Z-score

研究概览

简要总结

In this proposed clinical trial, the investigators will randomize 80 very preterm (VPT) infants to receive either early (between day 4 and 7) or delayed (between day 10 and 14) fortification and determine if providing early protein supplementation through early fortification results in higher FFM-for-age z scores and more diversity in the gut microbiome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
1 Day 至 4 Days(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Gestational age 29 to 33 weeks of gestation
  • •Birth weight < 1800 g
  • •Postnatal age < 96 hours

排除标准

  • •Small for gestational age (<5th percentile)
  • •Major congenital/chromosomal anomalies
  • •Terminal illness needing withhold or limit support

研究组 & 干预措施

Early human milk fortification (HMF) group

Experimental

A human milk fortifier will be added to the feeds between days 4 to 7, after a total feeding volume greater than 120 ml/kg/day is achieved.

干预措施: Early HMF (Dietary Supplement)

Delayed human milk fortification (HMF) group

Active Comparator

A human milk fortifier will be added to the feeds between days 10 to 14, after a total feeding volume greater than 120 ml/kg/day is achieved.

干预措施: Delayed HMF (Dietary Supplement)

结局指标

主要结局

Fat-free mass(FFM)-for-age Z-score

时间窗: Postnatal day 14 to 21

Estimated by air displacement plethysmography

次要结局

  • Growth - Head circumference(Birth to 36 weeks postmenstrual age or hospital discharge)
  • Growth rate(Birth to 36 weeks postmenstrual age or hospital discharge)
  • Number of participants with diagnosis of intestinal perforation(Birth to 10 days)
  • Death(Birth to 60 days)
  • Growth - Length(Birth to 36 weeks postmenstrual age or hospital discharge)
  • Fecal microbiome composition(Birth to 36 weeks postmenstrual age)
  • Duration of hospital stay in days(Birth to 60 days or discharge, whichever occurs first)
  • Growth - Weight(Birth to 36 weeks postmenstrual age or hospital discharge)
  • Number of participants with postnatal growth faltering(Birth to 36 weeks postmenstrual age or hospital discharge)
  • Number of participants with diagnosis of necrotizing enterocolitis(Birth to 60 days or discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ariel A. Salas

Associate Professor of Pediatrics

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验